U.S. flag

An official website of the United States government

NM_000053.4(ATP7B):c.3237T>A (p.Cys1079Ter) AND Wilson disease

Germline classification:
Pathogenic/Likely pathogenic (3 submissions)
Last evaluated:
Aug 10, 2021
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001263752.11

Allele description [Variation Report for NM_000053.4(ATP7B):c.3237T>A (p.Cys1079Ter)]

NM_000053.4(ATP7B):c.3237T>A (p.Cys1079Ter)

Gene:
ATP7B:ATPase copper transporting beta [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q14.3
Genomic location:
Preferred name:
NM_000053.4(ATP7B):c.3237T>A (p.Cys1079Ter)
HGVS:
  • NC_000013.11:g.51944115A>T
  • NG_008806.1:g.72380T>A
  • NM_000053.4:c.3237T>AMANE SELECT
  • NM_001005918.3:c.2616T>A
  • NM_001243182.2:c.2904T>A
  • NM_001330578.2:c.3003T>A
  • NM_001330579.2:c.2985T>A
  • NP_000044.2:p.Cys1079Ter
  • NP_001005918.1:p.Cys872Ter
  • NP_001230111.1:p.Cys968Ter
  • NP_001317507.1:p.Cys1001Ter
  • NP_001317508.1:p.Cys995Ter
  • NC_000013.10:g.52518251A>T
Protein change:
C1001*
Links:
dbSNP: rs1957506216
NCBI 1000 Genomes Browser:
rs1957506216
Molecular consequence:
  • NM_000053.4:c.3237T>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001005918.3:c.2616T>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001243182.2:c.2904T>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001330578.2:c.3003T>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001330579.2:c.2985T>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Wilson disease (WND)
Synonyms:
Wilson's disease; Hepatolenticular degeneration
Identifiers:
MONDO: MONDO:0010200; MedGen: C0019202; Orphanet: 905; OMIM: 277900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001441845Myriad Genetics, Inc.
criteria provided, single submitter

(Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2019))
Likely pathogenic
(Nov 4, 2019)
unknownclinical testing

Citation Link,

SCV001580267Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Aug 29, 2020)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV001977264Genome-Nilou Lab
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Aug 10, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation.

Buiakova OI, Xu J, Lutsenko S, Zeitlin S, Das K, Das S, Ross BM, Mekios C, Scheinberg IH, Gilliam TC.

Hum Mol Genet. 1999 Sep;8(9):1665-71.

PubMed [citation]
PMID:
10441329

Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease.

Gromadzka G, Schmidt HH, Genschel J, Bochow B, Rodo M, Tarnacka B, Litwin T, Chabik G, Członkowska A.

Clin Genet. 2005 Dec;68(6):524-32.

PubMed [citation]
PMID:
16283883
See all PubMed Citations (4)

Details of each submission

From Myriad Genetics, Inc., SCV001441845.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001580267.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change creates a premature translational stop signal (p.Cys1079*) in the ATP7B gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in ATP7B are known to be pathogenic (PMID: 10441329, 16283883). This variant has not been reported in the literature in individuals with ATP7B-related conditions. This variant is not present in population databases (ExAC no frequency).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Genome-Nilou Lab, SCV001977264.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024